Subscribe To
LPCN / Lipocine to Present at the H.C. Wainwright Annual NASH Investor Conference
LPCN News
By PRNewsWire
October 23, 2023
Lipocine to Present at the H.C. Wainwright Annual NASH Investor Conference
SALT LAKE CITY , Oct. 23, 2023 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on treating Central Nervous System (C more_horizontal
By PRNewsWire
January 5, 2023
Lipocine to Present at Biotech Showcase
Company Management Will Also Host Meetings at LifeSci Partners Corporate Access Event SALT LAKE CITY , Jan. 5, 2023 /PRNewswire/ -- Lipocine Inc. (NAS more_horizontal